Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis [PDF]
, 1995 Maria Paris +4 more
openalex +1 more source
Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agent
, 1990 George M. Eliopoulos +4 more
openalex +1 more source
Comparative in-vitro activity of the new fluoroquinolone trovafloxacin (CP-99,219) against Gram-positive cocci [PDF]
, 1996 Teresa M. Coque +2 more
openalex +1 more source
A novel gyrB mutation in a fluoroquinolone-resistant clinical isolate of Salmonella typhimurium [PDF]
, 1995 Karl Gensberg
openalex +1 more source
Fluoroquinolone restriction to control fluoroquinolone-resistant Clostridium difficile [PDF]
The Lancet Infectious Diseases, 2017 Curtis J. Donskey, Curtis J. Donskey
openaire +3 more sources
Emergence of Novel Fluoroquinolone Resistance Mutations in Mycoplasma bovis, China, 2008-2023. [PDF]
Emerg Infect DisLan S +12 more
europepmc +1 more source
In-vitro antimicrobial activity of HSR-903, a new fluoroquinolone, against clinical isolates of Neisseria gonorrhoeae with quinolone resistance-associated alterations in GyrA and ParC [PDF]
, 1997 T. Deguchi
openalex +1 more source
(Fluoro)quinolone prescriptions for upper respiratory tract infections in the German outpatient sector: a health insurance claims analysis. [PDF]
GMS Infect DisArens B +5 more
europepmc +1 more source
From Repurposing to Refinement: Optimizing Levofloxacin for Treatment of Multidrug-Resistant Tuberculosis. [PDF]
Am J Respir Crit Care MedYim JJ.
europepmc +1 more source